
Kane Biotech Investor Relations Material
Latest events

Investor Update
Kane Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Kane Biotech Inc
Access all reports
Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. Biofilms are complex communities of bacteria that can adhere to surfaces and are resistant to antibiotics and chemical agents. Kane Biotech's portfolio includes solutions for human health, animal health, and industrial applications, focusing on addressing challenges related to biofilm-related infections and contamination. The company is headquartered in Winnipeg, Canada, and its shares are listed on the TSX.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
KNE
Country
🇨🇦 Canada